
Chloroplasts (magenta color) in leaves expressing a green fluorescent protein. The DNA encoding for the protein was delivered by targeted nanomaterials without mechanical aid by applying a droplet of the nano-formulation to the leaf surface. (Israel Santana/UCR)
The future of vaccines may look more like eating a salad than getting a shot in the arm. UC Riverside scientists are studying whether they can turn edible plants like lettuce into mRNA vaccine factories.
Messenger RNA or mRNA technology, used in COVID-19 vaccines, works by teaching our cells to recognize and protect us against infectious diseases.
One of the challenges with this new technology is that it must be kept cold to maintain stability during transport and storage. If this new project is successful, plant-based mRNA vaccines — which can be eaten — could overcome this challenge with the ability to be stored at room temperature.
The project’s goals, made possible by a $500,000 grant from the National Science Foundation, are threefold: showing that DNA containing the mRNA vaccines can be successfully delivered into the part of plant cells where it will replicate, demonstrating the plants can produce enough mRNA to rival a traditional shot, and finally, determining the right dosage.
“Ideally, a single plant would produce enough mRNA to vaccinate a single person,” said Juan Pablo Giraldo, an associate professor in UCR’s Department of Botany and Plant Sciences who is leading the research, done in collaboration with scientists from UC San Diego and Carnegie Mellon University.
“We are testing this approach with spinach and lettuce and have long-term goals of people growing it in their own gardens,” Giraldo said. “Farmers could also eventually grow entire fields of it.”
Key to making this work are chloroplasts — small organs in plant cells that convert sunlight into energy the plant can use. “They’re tiny, solar-powered factories that produce sugar and other molecules which allow the plant to grow,” Giraldo said. “They’re also an untapped source for making desirable molecules.”
In the past, Giraldo has shown that it is possible for chloroplasts to express genes that aren’t naturally part of the plant. He and his colleagues did this by sending foreign genetic material into plant cells inside a protective casing. Determining the optimal properties of these casings for delivery into plant cells is a specialty of Giraldo’s laboratory.
For this project Giraldo teamed up with Nicole Steinmetz, a UC San Diego professor of nanoengineering, to utilize nanotechnologies engineered by her team that will deliver genetic material to the chloroplasts.
“Our idea is to repurpose naturally occurring nanoparticles, namely plant viruses, for gene delivery to plants,” Steinmetz said. “Some engineering goes into this to make the nanoparticles go to the chloroplasts and also to render them non-infectious toward the plants.”
For Giraldo, the chance to develop this idea with mRNA is the culmination of a dream. “One of the reasons I started working in nanotechnology was so I could apply it to plants and create new technology solutions. Not just for food, but for high-value products as well, like pharmaceuticals,” Giraldo said.
Giraldo is also co-leading a related project using nanomaterials to deliver nitrogen, a fertilizer, directly to chloroplasts, where plants need it most.
Nitrogen is limited in the environment, but plants need it to grow. Most farmers apply nitrogen to the soil. As a result, roughly half of it ends up in groundwater, contaminating waterways, causing algae blooms, and interacting with other organisms. It also produces nitrous oxide, another pollutant.
This alternative approach would get nitrogen into the chloroplasts through the leaves and control its release, a much more efficient mode of application that could help farmers and improve the environment.
Original Article: Grow and eat your own vaccines?
More from: University of California Riverside | Carnegie Mellon University
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
mRNA factories
- South Africa: The EU Protects Its Companies From Big Pharma. South Africa Needs to Do the Sameon December 7, 2023 at 1:45 am
Critical work done by South African scientists on mRNA vaccines for several diseases is at risk from patent claims from the pharmaceutical giant Moderna. Yet the government could easily protect this ...
- UAW to organize workers at all US nonunion factories after winning new contracts in Detroiton December 5, 2023 at 12:10 am
The UAW says the drive will cover nearly 150,000 workers at factories largely in the South, where the union has had little success in recruiting new members. ©2023 CBS Broadcasting Inc. All ...
- How a pathogenic bacterium uses molecular mimicry to compromise a cell's protein building factoryon December 4, 2023 at 4:00 pm
For cells to make proteins, they need to decode the language of the mRNA (nucleic acid) and translate that into the language of proteins (amino acid). This process is described in molecular biology ...
- Moderna Inc MRNAon December 4, 2023 at 5:00 am
The stellar efficacy and safety profile of Moderna's COVID-19 vaccine offered rapid validation of the firm's mRNA technology. Moderna's Alexion partnership was terminated in 2017 after failure to ...
- Rarity Factory Tycoon Codes (December 2023)on December 3, 2023 at 8:13 pm
If you love Roblox factory tycoon games, you will have a lot of fun with Rarity Factory Tycoon. Start your factory running and collect the orbs it produces, then place them in the orb processor to ...
Go deeper with Google Headlines on:
mRNA factories
[google_news title=”” keyword=”mRNA factories” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Plant-based mRNA vaccines
- Novavax's Updated COVID-19 Vaccine Now Authorized in Canadaon December 5, 2023 at 1:01 pm
Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that Health Canada has granted expanded authorization for Nuvaxovid™ XBB.1.
- Medicine, Technology and the End of Canceron December 5, 2023 at 7:00 am
Advancements in technology and science often occur in parallel silos, but when they converge, the results can be groundbreaking. The merging of mRNA and artificial intelligence exemplifies such a ...
- Rwanda: BioNTech's Rwanda-Based Vaccine Factory to Launch Mid-Decemberon December 1, 2023 at 12:10 am
Since 2021, the government of Rwanda has been working with BioNTech on the construction of a state-of-the-art manufacturing plant for mRNA-based vaccines. "Everyone is expecting the factory to be ...
- Moderna starts building mRNA plant in Chinaon November 28, 2023 at 6:21 am
Moderna (NASDAQ:MRNA) has started building its first production plant for messenger-RNA-based medicines in China. The new site is part of a collaboration agreement with the Shanghai government first ...
- BioVectra opening new mRNA vaccine manufacturing facility in P.E.I. as part of $90M expansionon November 17, 2023 at 2:01 am
Charlottetown-based pharmaceutical company BioVectra ... The new facilities include one of Canada's first mRNA vaccine biomanufacturing centres in Charlottetown. There is also a new biologics ...
Go deeper with Google Headlines on:
Plant-based mRNA vaccines
[google_news title=”” keyword=”plant-based mRNA vaccines” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]